NIH funding freeze stalls applications on $1.5B in medical research funds
npr.org
npr.org
And this is not the only way they're interfering with scientific research, the hard cap on indirect costs is probably the other most significant event. And all of this is on extremely short notice (or actually retroactive as it applies to grants that are already approved), which makes it even more destructive.
https://www.science.org/content/blog-post/pharma-ceos-speaki...
If you want to read a bit about all these event from the perspective of someone working in pharma I'd recommend Derek Lowe's blog:
> Some outside observers defended the situation.
> "A temporary pause in publicizing or funding new grants in order to review them is typical for a new administration," Judge Glock, director of research and a senior fellow at the Manhattan Institute, a conservative think tank, wrote in an email to NPR."